Prebiotic inulin-type fructans induce specific changes in the human gut microbiota (17 February, 2017)
Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future by leading authorities.
Gut is an official journal of the British Society of Gastroenterology.
This home page is under development
Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy (17 February, 2017)
Inflammatory bowel disease:
Tofacitinib for induction and maintenance therapy of Crohn’s disease: results of two phase IIb randomised placebo-controlled trials (16 February, 2017)
A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach (14 February, 2017)
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report (5 October, 2016)
Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer (15 November, 2016)
Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis (9 December, 2016)
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines (12 February, 2016)